Scenario Analysis of Vaccine Supply for COVID-19 in Japan Using Mathematical Models of Infectious Diseases

References

• Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. 2021. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 371:916–921. doi: 10.1126/science.abe6959.
   PubMed Web of Science ®Google Scholar
• Buckner JH, Chowell G, Springborn MR. 2021. Dynamic prioritization of covid-19 vaccines when social distancing is limited for essential workers. Proc Natl Acad Sci U S A. 118:e2025786118. doi: 10.1073/pnas.2025786118.
   Web of Science ®Google Scholar
• Castillo JC, Ahuja A, Athey S, Baker A, Budish E, Chipty T, Glennerster R, Kominers SD, Kremer M, Larson G, et al. 2021. Market design to accelerate COVID-19 vaccine supply. Science. 371:1107–1109. doi: 10.1126/science.abg0889.
   PubMed Web of Science ®Google Scholar
• Chang S, Pierson E, Koh PW, Gerardin J, Redbird B, Grusky D, Leskovec J. 2021. Mobility network models of COVID-19 explain inequities and inform reopening. Nature. 589:82–87. doi: 10.1038/s41586-020-2923-3.
   PubMed Web of Science ®Google Scholar
• Chen X, Li M, Simchi-Levi D, Zhao T. 2020. Allocation of COVID-19 vaccines under limited supply. medRxiv. doi: 10.1101/2020.08.23.20179820.
   Google Scholar
• Cooper I, Mondal A, Antonopoulos CG. 2020. A SIR model assumption for the spread of COVID-19 in different communities. Chaos Solitons Fractals. 139:110057. doi: 10.1016/j.chaos.2020.110057.
   PubMed Web of Science ®Google Scholar
• Economist Intelligence. 2021. Coronavirus vaccines: expect delays. [accessed 2022 Jul 2]. https://www.eiu.com/n/campaigns/q1-global-forecast-2021/.
   Google Scholar
• Fanelli D, Piazza F. 2020. Analysis and forecast of COVID-19 spreading in China, Italy and France. Chaos Solitons Fractals. 134:109761. doi: 10.1016/j.chaos.2020.109761.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. n.d. COVID-19 vaccines. [accessed 2022 Jul 2]. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines#basics.
   Google Scholar
• Frederiksen LSF, Zhang Y, Foged C, Thakur A. 2020. The long road toward COVID-19 herd immunity: Vaccine platform technologies and mass immunization strategies. Front Immunol. 11:1817. doi: 10.3389/fimmu.2020.01817.
   PubMed Web of Science ®Google Scholar
• Google. n.d. COVID-19 community mobility reports. [accessed 2022 Jul 2]. https://www.google.com/covid19/mobility/.
   Google Scholar
• Grimm V, Mengel F, Schmidt M. 2021. Extensions of the SEIR model for the analysis of tailored social distancing and tracing approaches to cope with COVID-19. Sci Rep. 11:4214. doi: 10.1038/s41598-021-83540-2.
   PubMed Web of Science ®Google Scholar
• Han S, Cai J, Yang J, Zhang J, Wu Q, Zheng W, Shi H, Ajelli M, Zhou XH, Yu H. 2021. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity. Nat Commun. 12:4673. doi: 10.1038/s41467-021-24872-5.
   PubMed Web of Science ®Google Scholar
• Hossain MK, Hassanzadeganroudsari M, Feehan J, Apostolopoulos V. 2021. The race for a COVID-19 vaccine: where are we up to? Expert Rev Vaccines. 21:355–376. doi: 10.1080/14760584.2022.2021074.
   PubMedGoogle Scholar
• Jakhar M, Ahluwalia PK, Kumar A. 2020. COVID-19 epidemic forecast in different states of India using SIR model. medRxiv. doi: 10.1101/2020.05.14.20101725.
   Google Scholar
• Japan Meteorological Agency. n.d. [accessed 2022 Jul 2]. https://www.jma.go.jp/jma/index.html.
   Google Scholar
• Kaddar A, Abta A, Alaoui HT. 2011. A comparison of delayed SIR and SEIR epidemic models. NAMC. 16:181–190. doi: 10.15388/NA.16.2.14104.
   Google Scholar
• Kim J, Matsunami K, Okamura K, Badr S, Sugiyama H. 2021. Determination of critical decision points for COVID-19 measures in Japan. Sci Rep. 11:16416. doi: 10.1038/s41598-021-95617-z.
   PubMed Web of Science ®Google Scholar
• Lee EK, Li ZL, Liu YK, Leduc J. 2021. Strategies for vaccine prioritization and mass dispensing. Vaccines (Basel). 9:506. doi: 10.3390/vaccines9050506.
   PubMed Web of Science ®Google Scholar
• Linka K, Peirlinck M, Kuhl E. 2020. The reproduction number of COVID-19 and its correlation with public health interventions. Comput Mech. 66:1035–1050. doi: 10.1007/s00466-020-01880-8.
   PubMed Web of Science ®Google Scholar
• Ma J. 2020. Estimating epidemic exponential growth rate and basic reproduction number. Infect Dis Model. 5:129–141. doi: 10.1016/j.idm.2019.12.009.
   PubMedGoogle Scholar
• Mallory ML, Lindesmith LC, Baric RS. 2018. Vaccination-induced herd immunity: Successes and challenges. J Allergy Clin Immunol. 142:64–66. doi: 10.1016/j.jaci.2018.05.007.
   PubMed Web of Science ®Google Scholar
• Matrajt L, Eaton J, Leung T, Brown ER. 2021. Vaccine optimization for COVID-19: Who to vaccinate first? Sci Adv. 7. doi: 10.1126/sciadv.abf1374.
   PubMed Web of Science ®Google Scholar
• Ministry of Economy, Trade and Industry. n.d. The strategy for strengthening the vaccine development and production system. [accessed 2023 May 12]. https://www.meti.go.jp/english/policy/mono_info_service/mono/bio/vaccine_development/index.html.
   Google Scholar
• Ministry of Health, Labour and Welfare, Open data. n.d. [accessed 2022 Jul 2]. https://www.mhlw.go.jp/stf/covid-19/open-data.html.
   Google Scholar
• National Institute of Infectious Diseases. 2021. The B.1.1.529 mutant strain of SARS-CoV-2 (Omicron strain) (5th Report); [accessed 2022 Jul 25]. https://www.niid.go.jp/niid/ja/2019-ncov/2551-cepr/10876-sars-cov-2-b-1-1-529.html.
   Google Scholar
• Prime Minister’s Office of Japan. n.d. COVID-19 vaccines. [accessed 2022 Jul 2]. https://www.kantei.go.jp/jp/headline/kansensho/vaccine.html.
   Google Scholar
• Shu H, Fan D, Wei J. 2012. Global stability of multi-group SEIR epidemic models with distributed delays and nonlinear transmission. Nonlinear Anal Real World Appl. 13:1581–1592. doi: 10.1016/j.nonrwa.2011.11.016.
   Web of Science ®Google Scholar
• So AD, Woo J. 2020. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 371:m4750. doi: 10.1136/bmj.m4750.
   PubMed Web of Science ®Google Scholar
• Sobol’ IM. 1990. On sensitivity estimation for nonlinear mathematical models. Matem Mod. 2:112–118.
   Google Scholar
• Word Health Organization. n.d. COVID-19 vaccine tracker and landscape. [accessed 2022 Jul 2]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
   Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. 2021. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 397:1023–1034. doi: 10.1016/S0140-6736(21)00306-8.
   PubMed Web of Science ®Google Scholar
• Xu C, Yu Y, Chen YQ, Lu Z. 2020. Forecast analysis of the epidemics trend of COVID-19 in the USA by a generalized fractional-order SEIR model. Nonlinear Dyn. 101:1621–1634. doi: 10.1007/s11071-020-05946-3.
   PubMed Web of Science ®Google Scholar
• Xue QC, Ouellette LL. 2020. Innovation policy and the market for vaccines. J Law Biosci. 7:lsaa026. doi: 10.1093/jlb/lsaa026.
   PubMed Web of Science ®Google Scholar